Holen Sie sich die Stockscreener-App
0.063
21.75%
-0.017
Schlusskurs vom Vortag:
$0.08
Offen:
$0.08
24-Stunden-Volumen:
9,823
Relative Volume:
0.31
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.56M
KGV:
-0.00557
EPS:
-11.31
Netto-Cashflow:
$-6.30M
1W Leistung:
-21.75%
1M Leistung:
+3.99%
6M Leistung:
-8.08%
1J Leistung:
-99.85%
1-Tages-Spanne:
$0.063
$0.0819
1-Wochen-Bereich:
$0.053
$0.0702
52-Wochen-Spanne:
$0.046
$0.10
Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile
Firmenname
Hepion Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HEPA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HEPA
Hepion Pharmaceuticals Inc
|
0.063 | 0 | 0 | -13.56M | -6.30M | -11.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.38 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
804.23 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.87 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.92 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
169.59 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-07-20 | Fortgesetzt | ROTH Capital | Buy |
Hepion Pharmaceuticals Inc Aktie (HEPA) Neueste Nachrichten
Will Hepion Pharmaceuticals Inc. stock split attract more investorsQuarterly Portfolio Report & Long-Term Growth Stock Strategies - ulpravda.ru
Why Hepion Pharmaceuticals Inc. stock could see breakout soonJuly 2025 WrapUp & Fast Entry High Yield Tips - ulpravda.ru
Book value per share of Hepion Pharmaceuticals, Inc. – MUN:3360 - TradingView — Track All Markets
Travel Stocks: Will Hepion Pharmaceuticals Inc stock split attract more investorsEarnings Growth Summary & Stock Portfolio Risk Management - moha.gov.vn
HEPA (Hepion Pharmaceuticals) EV-to-FCF : -0.10 (As of Dec. 22, 2025) - GuruFocus
Can Hepion Pharmaceuticals Inc. (336) stock sustain breakout momentum2025 Big Picture & Fast Moving Trade Plans - Улправда
Is Hepion Pharmaceuticals Inc. stock a bargain at current levels2025 EndofYear Setup & Growth Focused Investment Plans - DonanımHaber
Will Hepion Pharmaceuticals Inc. (336) stock see insider accumulation2025 Risk Factors & Real-Time Sentiment Analysis - DonanımHaber
How Hepion Pharmaceuticals Inc. stock compares to growth peersJuly 2025 Movers & Weekly Momentum Stock Picks - DonanımHaber
Will Hepion Pharmaceuticals Inc. stock see PE expansionMarket Sentiment Review & Stepwise Entry and Exit Trade Signals - DonanımHaber
What is the fair value of Hepion Pharmaceuticals Inc. stock nowPortfolio Growth Summary & Accurate Intraday Trade Tips - Улправда
Why Hepion Pharmaceuticals Inc. stock could rally in 2025Trade Exit Report & Fast Gain Swing Trade Alerts - Улправда
Growth Report: How Hepion Pharmaceuticals Inc. stock trades during market volatilityGap Up & Risk Controlled Daily Trade Plans - Улправда
Why Hepion Pharmaceuticals Inc. stock is considered a top pickRisk Management & Reliable Breakout Forecasts - Улправда
Will Hepion Pharmaceuticals Inc. (336) stock outperform foreign stocksQuarterly Profit Report & Real-Time Volume Analysis - Newser
Why Hepion Pharmaceuticals Inc. (336) stock benefits from AI revolutionJuly 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
How Hepion Pharmaceuticals Inc. (336) stock reacts to Fed tighteningWeekly Trade Review & Entry Point Confirmation Signals - Newser
Is Hepion Pharmaceuticals Inc. (336) stock undervalued historicallyVolume Spike & Reliable Price Action Trade Plans - Newser
How Hepion Pharmaceuticals Inc. (336) stock behaves under inflation pressureMarket Risk Analysis & Weekly High Potential Stock Alerts - Newser
What dividend safety score for Hepion Pharmaceuticals Inc. stockWeekly Investment Recap & Weekly Breakout Stock Alerts - Newser
Is Hepion Pharmaceuticals Inc. (336) stock a good hedge against inflationTrade Analysis Summary & Safe Entry Trade Reports - newser.com
Is Hepion Pharmaceuticals Inc. stock attractive after correctionJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Can Hepion Pharmaceuticals Inc. stock sustain revenue growth2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Will Hepion Pharmaceuticals Inc. (336) stock benefit from infrastructure bill2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
Is Hepion Pharmaceuticals Inc. (336) stock resilient in recession scenariosEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Does Hepion Pharmaceuticals Inc. show high probability of reboundEarnings Overview Summary & Smart Money Movement Alerts - newser.com
Trend analysis for Hepion Pharmaceuticals Inc. this weekWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
How Hepion Pharmaceuticals Inc. (336) stock valuation compares with sectorTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
Candlestick signals on Hepion Pharmaceuticals Inc. stock todayPortfolio Gains Report & Technical Confirmation Trade Alerts - newser.com
Finanzdaten der Hepion Pharmaceuticals Inc-Aktie (HEPA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.77%
Kapitalisierung:
|
Volumen (24h):